Market Closed -
Euronext Paris
11:35:16 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
882
EUR
|
+0.57%
|
|
+2.32%
|
+6.27%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,108
|
2,079
|
2,246
|
1,737
|
1,716
|
1,833
|
-
|
-
|
Enterprise Value (EV)
1 |
2,084
|
2,003
|
2,168
|
1,907
|
1,716
|
1,940
|
1,889
|
1,833
|
P/E ratio
|
40.2
x
|
41.4
x
|
31.5
x
|
23
x
|
23.2
x
|
23.8
x
|
22.6
x
|
-
|
Yield
|
0.54%
|
0.62%
|
0.82%
|
0.96%
|
1.02%
|
1.09%
|
1.18%
|
-
|
Capitalization / Revenue
|
3.8
x
|
3.86
x
|
3.71
x
|
2.47
x
|
2.38
x
|
2.35
x
|
2.24
x
|
-
|
EV / Revenue
|
3.76
x
|
3.72
x
|
3.58
x
|
2.71
x
|
2.38
x
|
2.48
x
|
2.31
x
|
-
|
EV / EBITDA
|
-
|
-
|
18.5
x
|
-
|
12.9
x
|
13.4
x
|
12.1
x
|
10.2
x
|
EV / FCF
|
44.2
x
|
23.2
x
|
33.7
x
|
74.3
x
|
-
|
27.6
x
|
22.6
x
|
-
|
FCF Yield
|
2.26%
|
4.31%
|
2.97%
|
1.35%
|
-
|
3.62%
|
4.43%
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
2,308
|
2,310
|
2,312
|
2,087
|
2,080
|
2,089
|
-
|
-
|
Reference price
2 |
923.0
|
905.0
|
975.0
|
837.0
|
830.0
|
882.0
|
882.0
|
882.0
|
Announcement Date
|
5/5/20
|
4/30/21
|
4/29/22
|
5/2/23
|
4/11/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
554.3
|
538.3
|
606.1
|
703
|
721.1
|
781.6
|
817.4
|
-
|
EBITDA
1 |
-
|
-
|
117.5
|
-
|
133
|
145
|
155.8
|
180
|
EBIT
1 |
73.04
|
71
|
93.59
|
101.9
|
111.4
|
120.5
|
126.7
|
-
|
Operating Margin
|
13.18%
|
13.19%
|
15.44%
|
14.5%
|
15.45%
|
15.42%
|
15.5%
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
93.67
|
-
|
100.2
|
-
|
-
|
-
|
Net income
1 |
53.04
|
50.58
|
71.71
|
76.02
|
74.6
|
85.6
|
90.2
|
-
|
Net margin
|
9.57%
|
9.4%
|
11.83%
|
10.81%
|
10.34%
|
10.95%
|
11.04%
|
-
|
EPS
2 |
22.96
|
21.87
|
31.00
|
36.41
|
35.71
|
37.07
|
39.09
|
-
|
Free Cash Flow
1 |
47.15
|
86.24
|
64.34
|
25.66
|
-
|
70.15
|
83.7
|
-
|
FCF margin
|
8.51%
|
16.02%
|
10.62%
|
3.65%
|
-
|
8.98%
|
10.24%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
54.74%
|
-
|
-
|
48.36%
|
53.71%
|
-
|
FCF Conversion (Net income)
|
88.89%
|
170.5%
|
89.72%
|
33.75%
|
-
|
81.95%
|
92.79%
|
-
|
Dividend per Share
2 |
5.000
|
5.600
|
8.000
|
8.000
|
8.500
|
9.635
|
10.38
|
-
|
Announcement Date
|
5/5/20
|
4/30/21
|
4/29/22
|
5/2/23
|
4/11/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
170
|
-
|
107
|
55.8
|
-
|
Net Cash position
1 |
24.2
|
76.4
|
77.3
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.7363
x
|
0.358
x
|
-
|
Free Cash Flow
1 |
47.2
|
86.2
|
64.3
|
25.7
|
-
|
70.2
|
83.7
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
18.3%
|
-
|
15.9%
|
14.9%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
9.32%
|
-
|
8.7%
|
8.5%
|
-
|
Assets
1 |
-
|
-
|
-
|
815.3
|
-
|
983.9
|
1,061
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
20.8
|
21.1
|
-
|
21
|
21.5
|
24
|
Capex / Sales
|
-
|
-
|
3.43%
|
3%
|
-
|
2.69%
|
2.63%
|
-
|
Announcement Date
|
5/5/20
|
4/30/21
|
4/29/22
|
5/2/23
|
4/11/24
|
-
|
-
|
-
|
Average target price
1,065
EUR Spread / Average Target +20.75% Consensus |
1st Jan change
|
Capi.
|
---|
| +6.27% | 1.96B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|